Market Access EMA’s strategy for speeding up drug approvals in the EU The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike
Market Access FDA approval numbers soar after COVID troubles The FDA released its overview of 2023 and the drugs it had approved during the year.
News RFK Jr defends HHS cuts, measles stance in Congress hearings HHS Secretary Robert F Kennedy Jr would not explicitly endorse measles vaccines at Congressional hearings, and deflected questions on department cuts.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.